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A new method for high incorporation of PHJinositol into human platelets is described. The method involves incorpora- 
tion of PH]inositol during reversible lectropermeabilisation by high voltage discharge, followed by resealing the cells 
during incubation at 37°C. Between IO- and 20-fold increase of isotope uptake is achieved compared to control intact 
cells. Permeabilised resealed platelets maintain good responses to thrombin and collagen. Analysis of the incorporation 
of the label amongst he phosphoinositides shows 70% to be in PI, 20% in PIP, and 10% in PIP,. Stimulation with thromb- 
in and analysis of the formation of IP,, IP, and IP, shows the labelling to occur in a hormone-sensitive pool. These 
studies indicate that reversible lectropermeabilisation can be used to achieve good uptake of non-membrane penetrating 
substances such as inositol. 
Inositol uptake, PHI; Reversible lectropermeabilisation, (Human platelet) 
1. INTRODUCTION 
Over the last few years the link between receptor 
activation, phosphoinositide metabolism and intra- 
cellular Ca2+ mobilisation in cells and tissues, has 
been the focus of considerable research interest. In 
blood platelets such intracellular biochemical 
events are also associated with the action of certain 
agonists as part of their normal haemostatic func- 
tions. Although other transmembrane signalling 
mechanisms also exist in platelets it is now well 
established that the action of agonists such as 
thrombin, platelet activating factor (PAF), throm- 
boxane AZ, PGH2 and serotonin can all result in 
the degradation of phosphoinositides and the for- 
mation of the second messengers IP3 (inositol 
1,4,5_trisphosphate) and 1,2-diacylglycerol [l-4]. 
The former metabolite is involved in regulating 
Ca2+ movement out of intracellular storage com- 
partments [5] and the diacylglycerol is associated 
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with the action of protein kinase-C in important 
phosphorylation mechanisms [6]. Such findings 
have led to an interest in radioactively labelling the 
platelet phosphoinositide pool so as to follow 
routes of metabolism and synthesis during agonist- 
induced activation. A major difficulty experimen- 
tors face, however, in the planning of dynamic 
studies of the phosphoinositide pools, is that one of 
the most appropriate labels [3H]inositol penetrates 
the platelet plasma membrane very poorly and the 
rate and extent of its incorporation into phospho- 
inositides are extremely low. Although alterations 
to the incubation medium (e.g. lowering the 
glucose concentration and addition of Mn2+) have 
been reported to enhance the level of incorpora- 
tion, generally the increases observed have been 
rather modest [7,8]. Additionally with platelets, 
long incubation times, which can carry the risk of 
surface and intracellular protease attack, may be 
necessary. 
Recently we have reported the construction of 
suitable equipment and the establishment of op- 
timum conditions for reversibly electropermeabilis- 
ing the plasma membrane of human and animal 
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platelets using cycles of high-voltage discharge [9]. 
With optimum voltage conditions and the ap- 
propriate number of high-voltage discharge cycles, 
the membrane can be rendered permeable to small 
molecular mass substances (nucleotides, fluores- 
cent probes, inositol phosphates etc.) and resealed 
without loss of morphological and functional in- 
tegrity. Greater than 86% of rat platelets and close 
to 100% of human platelets became permeable 
during the high-voltage discharge and reseal after a 
period of incubation at 37°C. Full receptor status 
for activating ligands is well maintained and, if 
ATP is included in the medium during the 
permeabilisation, aggregation and secretion 
responses differ little from those seen with control 
non-permeabilised platelets. Moreover, in studies 
with rat platelets, the reinfusion into the circula- 
tion of permeabilised and resealed platelets labelled 
with “‘Indium results in essentially normal life 
span characteristics [9]. 
In this paper we describe the use of this permea- 
bilisingiresealing protocol to enhance the incor- 
poration of [3H]inositol into the human platelet 
phosphoinositide pools. Between lo- and 20-fold 
increases in [3H]inositol uptake can be achieved 
when compared with non-permeabilised control 
cells. The time course of incorporation can be 
reduced, thus avoiding proteolytic artefacts and 
importantly, reasonable radioactive counts can be 
obtained for metabolites at substantially lower ex- 
ternal concentrations of the label. Experimental 
costs are thus substantially less than with intact cell 
labelling. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
All reagents were of analytical grade wherever possible and 
solutions prepared in either bidistilled water or analytical grade 
water (BDH, Poole, Dorset). The nucleotides ATP, CTP and 
ITP were obtained from Sigma, Poole, Dorset, as also were 
thrombin and the phospholipid standards PI, PIP and PIPr. 
The [3H]inositol (110 Ci/mmol) and [‘H]IPs (1.5 Ci/mmol) 
were purchased from Amersham International, UK. The ap- 
paratus used for electropermeabilisation was based upon a 
design reported by Knight and Scrutton [lo] and constructed by 
Rank Bros Ltd, of Bottisham, Cambridge, England. Details of 
this equipment and the discharge chamber have been reported in 
an earlier communication [9]. The discharge chamber for 
platelets has a capacity of = 900 pl and the gap between the elec- 
trodes is 3 mm. The capacitor discharge was estimated to decay 
exponentially with a half-life of about 13 gs under the condi- 
tions suitable for platelet permeabilisation and temperature 
changes within the chamber were negligible. 
2.2. Preparation of platetet suspensions and 
electropermeabilisation 
All platelet preparations were made from citrate anti- 
coagulated blood as reported in detail in earlier publications 
[9,11]. In some experiments the platelets were prelabelled with 
5-hydroxy(r4C]tryptamine and this was carried out at the 
platelet-rich plasma (PRP) stage before isolation and washing. 
After separation from the PRP and resuspension and acidifica- 
tion to pH 6.5 with citric acid they were centrifuged (1200 x g 
for 10 min) and resuspended in the ‘permeabilising buffer’ 
which consisted of 150 mM potassium glutamate, 20 mM Pipes, 
7 mM MgCl2, 5 mM potassium ATP, 5 mM glucose and 1 mM 
EGTA. This buffer was adjusted to pH 7.4 and 100 nM PGEi 
was included before suspending the cells. After a period of 
equilibration in this buffer (-- 45 min at room temperature) ali- 
quots of the platelet suspension (5-8 x 10’ cells/ml) were care- 
fully transferred to the discharge chamber avoiding bubble for- 
mation. In some experiments CTP or ITP (5 mM) were sub- 
stituted for the ATP in the buffer and if all nucleotides were 
omitted the MgClz concentration was reduced to 2 mM. For the 
electropermeabilisation generally 7 cycles of high-voltage dis- 
charge were used applied at 30-60 s intervals at the stated dis- 
charge voltages (see results). The efficacy of the permeabilisa- 
tion and resealing, which occurs when the suspension is in- 
cubated at 37°C (30-60 min), was monitored by including 
Lucifer yellow (500 pg/ml) in some suspensions and examina- 
tion of the cells by fluorescent microscopy, as earlier described. 
More routinely the permeabilisation and resealing can be 
monitored by an apparent upward platelet volume shift when 
aliquots of the cell suspension (transferred to ISOTON II) are 
immediately volume analysed using a resistive particle counter 
(Coulter ZM with C256 Channelyser). In experiments involving 
[3H]inositol incorporation the label was included in the 
permeabilisation buffer before application of the discharge 
cycles. Resealed platelets were allowed to return to room 
temperature, acidified to pH 6.5 with citric acid, centrifuged 
(500 x g 15 min) and then resuspended at a concentration of 
3 x 10’ cells/ml in a Ca2+-free tyrode medium consisting of 
135 mM NaCI, 4 mM KCl, 6 mM NaHCOs, 0.5 mM 
NaHsP04,l mM glucose, 10 mM Hepes, 1 mM MgC12, pH 7.4. 
Aggregation studies were carried out with 0.5 ml aliquots of 
platelet suspension using a Payton 300B dual channel ag- 
gregometer. Secretion studies with platelets prelabelled with 
[i4C]5HT were performed exactly as described in earlier reports 
I%lll. 
2.3. Analysis of tH]phosphoinositides rH]inositolphosphates 
The [‘HJinositol-labelled lipids were extracted from 3 x 10’ 
platelets using the procedure described by Billah and Lapetina 
[12] with a solvent consisting of chloroform/methanol/cone. 
HCI (20:40: 1, v/v). The chloroform extracts were applied to 
TLC plates pre-impregnated with 1% potassium oxalate in 
10 mM EDTA, pH 6.5. Separation of the different phospho- 
inositides was carried out with the solvent system chloro- 
form/methanol/4 M NH40H (9:7:2, v/v) with standards to 
assist location. Bands were visualised using iodine vapour and 
the areas corresponding to PI, PIP and PIP2 scraped off and the 
radioactivity counted by liquid scintillation counting. Analysis 
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of the formation of inositol phosphates was carried out exactly 
using the method of Downes and Wusteman [13] using Dowex- 
formate columns. Platelet suspensions (0.5 ml) were treated 
with thrombin (1 U/ml) for 15, 30 and 45 s and stopped with 
400~1 ice-cold 15% TCA. The mixtures were then extracted 
with ether, neutralised with 5 mM disodium tetraborate, ap- 
plied to 2.0 x 0.5 cm Dowex-formate columns and the inositol 
phosphates eluted with increasing concentrations of ammonium 
formate. The eluates were collected in 2 ml fractions and from 
each a 250 ~1 aliquot was taken for scintillation counting. All 
fractions containing concentrations of ammonium formate 
greater than 0.8 M required the addition of 1 ml of water to the 
scintillant mixture to overcome quenching effects. The eluted 
peaks were identified using [3H]inositol phosphate standards. 
3. RESULTS 
Earlier studies have shown that human platelets 
exposed to 7 discharge cycles at field strengths be- 
tween 6 and 8 kV/cm become freely permeable to 
small molecular mass substances (limit 600 Da). 
Incubation at 37°C for 30-60 min results in reseal- 
ing, the plasma membrane integrity is restored and 
this permeability is lost. Studies with non- 
membrane penetrating fluorescent probes have 
demonstrated that after resealing >85% of rat 
platelets and close to 100% of human platelets con- 
tained the encapsulated fluorochrome [9]. Routine- 
ly the efficacy of electropermeabilisation was 
followed by Coulter Counter volume analysis. 
Permeabilisation of the platelet membrane in the 
high K+ medium is associated with an upward shift 
in ‘apparent modal volumes’ from 6-7 fl to as high 
as 12-14 fl when the platelets are transferred to 
ISOTON II for size analyses. After 60 min incuba- 
tion in the high K+ medium after electrical dis- 
charge treatment and then transfer to ISOTON II, 
the normal size distribution profile is restored [9]. 
Fig. 1 shows that the inclusion of 8 pCi/ml [3H]- 
inositol in the surrounding buffer medium during 
the high-voltage discharge cycles (7 cycles at 
7 kV/cm) results in a maximum uptake of the label 
occurring around 60 min at which time the intra- 
cellular content of the label is at least 15-20 times 
higher than can be achieved with non- 
permeabilised control platelets exposed to the same 
concentration of [‘Hlinositol. That the uptake 
plateau is in full accord with the studies of the 
resealing time course using fluorescent probes, and 
other radiolabelled agents, as also with the restora- 
tion of normal volume profiles in the Coulter size 
analyser. Similarly, Ca’+-induced granule 5HT 
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Fig.1. Time course of [‘Hlinositol incorporation into 
permeabilised resealed human platelets. Cells were resuspended 
at 8 x 10’ cells/ml and electropermeabilised at 7 kV/cm (7 dis- 
charges) (A) in the presence of 8 &i/ml [‘Hlinositol, before in- 
cubation at 37°C for various times. Aliquots (100~1) were 
removed and placed in 0.4 CM filters and washed rapidly with 
3 x 5 ml of cold buffer. The filters were counted by liquid scin- 
tillation. Intact cells (0) were treated identically except hat no 
permeabilisation was carried out. 
secretion and IP3 stimulated release of intra- 
cellularly sequestered Ca’+, two properties well ex- 
pressed immediately after high-voltage discharge, 
are no longer demonstrable after the incubation 
period for resealing [9]. In the series of investiga- 
tions reported here the uptake of [‘Hlinositol into 
non-permeabilised control platelets amounted to 
0.34% + 0.11 (n = 4) of the available external abel 
and with five different platelet suspensions 
permeabilised and resealed at 7 kV/cm in the 
presence of 8 &i/ml [3H]inositol, the mean up- 
take into the cells was 3.6% * 1.9 (n = 5) of the 
available label. Studies were also carried out to 
establish the optimim high-voltage discharge con- 
ditions for this inositol uptake and for the 
maintenance of morphological and functional in- 
tegrity after resealing with respect to receptor 
status for the activators thrombin and collagen. 
Fig.2 shows that with 7 discharge cycles, at field 
strengths between 7 and 14 kV/cm, the uptake of 
‘H increases with increasing field strengths and, at 
11 kV/cm, the 070 within the cells of available label 
was >20-fold higher than for control platelets 
from the same donor not exposed to the 
permeabilisation/resealing protocol. With respect 
to agonist induced aggregation responses, at field 
strengths of 7 and 9 kV/cm, thrombin (0.2 U/ml) 
gave good activation responses with only small 
decreases in % aggregation (90 and 86% of con- 
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Fig.2. The effects of different voltages during electro- 
permeabilisation on [3H]inositol uptake and activation 
responses to thrombin in permeabilised resealed platelets. All in- 
cubations contained 8 &i/ml [‘Hlinositol in the permeabilisa- 
tion buffer. Platelet suspensions were electropermeabilised with 
7 discharges at different voltages and then incubated for 2 h at 
37°C. The cells were then centrifuged and resuspended before 
estimations of [‘Hlinositol uptake and aggregation responses 
(extents) to 0.2 U/ml thrombin were made. Results are ex- 
pressed as % uptake ( f SD) of ‘H label recovered in cells with 
respect o total added in the original incubation. Percentage up- 
take for [3H]inositol for 14 kV/cm was not determined. Control 
cells (0 kV) were treated identically except no permeabilisation 
was performed. Extent of aggregation to thrombin is expressed 
as a percentage of that obtained with control non-permeabilised 
platelets. 
trols respectively), as did collagen also (10 ,ug/ml, 
results not shown). The aggregation response after 
7 cycles at 11 kV/cm were however substantially 
reduced (to around 25% of controls) and at 
14 kV/cm the response to thrombin was effectively 
lost (<5% of controls). Previous studies have 
shown that with 7 discharge cycles at 14 kV/cm 
followed by an incubation period, the addition of 
Ca2+ at 10e5 M to the external medium in the 
presence of 5 mM ATP resulted in a 40% release of 
granule stored 5-hydroxy[‘4C]tryptamine [9]. It 
therefore appears that under these higher discharge 
conditions the membrane remains permeable, 
allows the influx of Ca2+ and granule membranes 
can fuse to the plasma membrane for exocytosis. 
The receptor status for surface activating ligands 
may be compromised or some features of the signal 
transduction mechanisms affected at discharge 
levels > 11 kV/cm. Because intracellular adenine 
nucleotides are lost during permeabilisation, all 
permeabilisation and resealing studies here have 
been carried out in a medium containing 5 mM 
ATP. In the lipid cycle concerned with the forma- 
tion of phosphatidylinositol, CTP is a vital inter- 
mediate. However, substitution of either CTP or 
ITP (at 5 mM) for the ATP in the surrounding 
medium during electropermeabilisation 
(8.5 kV/cm, 7 cycles) gave essentially the same 
values as ATP for uptake of [3H]inositol (6.2 and 
6.7% uptake of the available label, respectively). 
Surprisingly, under the same field strength condi- 
tions the omission of nucleotide completely from 
the external medium appeared to have little effect 
upon the % of externally available [3H]inositol 
taken up by the platelets (results not shown). Such 
platelets were, however, difficult to resuspend after 
centrifugation and rarely showed the classical 
swirling birefringence seen when platelets in 
suspension are of single cell identity. The inclusion 
of 5 mM ATP was therefore adopted routinely. 
Table 1 
Distribution of [3H]inositol in platelet phosphatidylinositides 
Phospholipid Electropermeabilised and resealed 
Control non- Prep. 2 Prep. 3 
permeabilised (dpm) (dpm) 
prep. 1 
(dpm) 
Phosphatidylinositol 928 (74.3%) 41174 (75.4%) 51142 (67.2%) 
Phos. ins 4-P 194 (15.6%) 9083 (16.6%) 18214 (23.9%) 
Phos. ins 4,5-PZ 126 (10.0%) 4373 (8.0%) 6802 (8.9%) 
Lipids are extracted from [3Hjinositol-labelled platelets (3 x lOa cells) as 
described in section 2. Three typical preparations are shown with similar 
results obtained in at least 10 other preparations. Prep. 1 is non- 
permeabilised platelets, prep. 2 and 3 are permeabilised and resealed 
platelets using 7 discharges of 8.5 kV/cm. All preparations contained 
8 &i/ml [3H]inositol during the uptake incubation (2 h), see section 2 
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Analyses of the distribution of [‘Hlinositol in- 
corporated into the platelet phosphoinositide pools 
were carried out after extraction and separation by 
thin layer chromatography. Table 1 shows the 
distribution profile for two typical experiments in 
which the platelets were exposed to [3H]inositol 
during permeabilisation with 7 discharge cycles at a 
field strength of 8 kV/cm followed by a 2 h in- 
cubation at 37°C. Amongst the phosphoinositides, 
phosphatidylinositol accounted for 67-7970 of the 
incorporated [3H]inositol abel with lesser amounts 
in phosphatidylinositol 4-phosphate (PIP, 
Amm.Form.Solns. 
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Fig.3. Thrombin-induced formation of inositol phosphates in 
[‘Hlinositol-labelled permeabilised resealed platelets (7 kV/cm, 
2 h incubation at 37°C). (a) Typical Dowex-formate 
chromatography of control (A) and 30 s thrombin stimulated 
(0) production of inositol phosphates. Ammonium formate 
solutions in 0.1 M formic acid used to elute inositol phosphates 
are shown in blocks above the profiles. The control profile (no 
thrombin) showed no peaks of activity corresponding to IPZ and 
IPs, but an IPi peak was present (total counts 11700 dpm). (b) 
Time course of 1 U/ml thrombin induced increase in inositol 
phosphate formation. Points are means f SE (n = 3), or means 
of duplicate determinations, after subtraction from control in- 
cubations of platelets without thrombin treatment. Symbols 
represented are (A) IPI, (0) IP2, (m) IPi. 
15-24070) and in phosphatidylinositol 4,5bisphos- 
phate (PIPz, 8-10%). These distribution values are 
broadly in keeping with the reported figures for the 
relative concentrations of these phosphoinositides 
in normal platelet membranes [8,14]. In terms of 
raw counts, these were between 35 and 55 times 
higher for the permeabilised/resealed platelet than 
could be achieved with control non-permeabilised 
platelets exposed to the same amount of [3H]- 
inositol (table 1). 
Further experiments were performed in which 
the production of [3H]inositol phosphate; was 
monitored after exposure of [3H]inositol-labelled 
and resealed platelets to thrombin (1 U/ml). The 
period of exposure to thrombin was varied between 
15 and 45 s before stopping its effect with TCA (see 
section 2). Separation of the inositol phosphates by 
Dowex-formate column chromatography (fig.3a) 
revealed that 3H-labelled IPi, IP2 and IPs were all 
present in detectable amounts at 15 s after addition 
of thrombin (fig.3b), but the relationship between 
the level of label associated with each of these 
metabolites changed substantially with increased 
time of exposure to thrombin. Whereas the counts 
for the predominant metabolite IPz increased ap- 
proximately linearly over the 45 s, IP3 formation 
peaked at 30 s and then decreased and IP forma- 
tion plateaued at 15 s and was maintained at this 
level without significant change thereafter. In these 
studies lithium was not included to inhibit hydro- 
lysis of inositol phosphate(s). 
4. DISCUSSION 
For studies of the metabolism of phospho- 
inositides and the production of inositol phos- 
phates in human platelets a major limitation is the 
small amount of [3H]inositol that can be incor- 
porated into intact cells so that the formation of 
metabolites can be followed sequentially. Incuba- 
tion periods in the presence of the label may extend 
to some hours and uptakes as low as 0.3-0.5% of 
the externally available label are commonly 
reported. In consequence high specific activities of 
externally applied [‘Hlinositol are required in 
order to give reasonable counts in individually 
separated lipid components. There are species dif- 
ferences, however, for example, rabbit platelets are 
able to incorporate [3H]inositol at higher rates than 
human platelets [15-171. In this paper we report the 
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use of reversibly electropermeabilised platelets to 
introduce high concentrations of [3H]inositol into 
normal human platelets. With as little as 8 &i/ml 
[3H]inositol in the externally applied medium over 
6% of the available label is taken up and good in- 
corporation occurs into the phosphoinositide 
pools. Our electropermeabilising unit, whose 
design is similar to that used by others [10,18], 
generates a high-voltage discharge across elec- 
trodes 3 mm apart in a chamber of about 
800-1000 ,~l volume. Earlier investigations have 
shown that = 7 discharge cycles at field strengths of 
7-8 kV/cm gave negligible losses of lactate de- 
hydrogenase and free diffusion into the cytosol 
compartment of substances of molecular mass of 
~600 Da [9]. Incubation at 37’C for 30-60 min 
encourages pontaneous resealing and the platelets’ 
morphological and metabolic integrity are well 
preserved, as is their surface receptor status for ac- 
tivating ligands. Comparative determinations of 
the uptake of [3H]inositol in control non- 
permeabilised platelets and reversibly electro- 
permeabilised platelets from the same preparations 
showed that in the latter cells lo-20-fold higher 
amounts of the label can be taken up. Analysis of 
the labelled phosphoinositides PI, PIP and PIP2 in 
the reversibly permeabilised platelets revealed 
counts between 30- and 50-fold higher for these 
lipids than found in extracts from control platelets. 
The % distribution of counts between these phos- 
pholipid species approximated those reported by 
other workers using much higher levels of external 
[3H]inositol [2,4,19,20] and broadly reflected by 
their known proportional distribution in normal 
platelet membranes [141. 
Studies in which the production of inositol phos- 
phates was monitored within the first minute after 
exposing the prelabelled permeabilised and reseal- 
ed platelets to thrombin revealed that the label in- 
corporates into a hormone-sensitive metabolic 
pool. Inositol bisphosphate (IP2) which was the 
predominant metabolite increased over this time 
course. The counts in IP3 peaked at 30 s and 
decreased thereafter and the IP associated counts 
plateaued after 15 s. This pattern of inositol phos- 
phate production is similar to those results 
reported by others where lithium is not used to in- 
hibit IP breakdown [2]. The degradation of phos- 
phatidylinositols is known to be induced in 
platelets by agonists such as thrombin and TXA2 
although there is still considerable controversy cor- 
relating Ca2+ mobilisation with inositol phosphate 
formation as a primary event for agonists such as 
ADP and collagen [21-231. Thus there is much in- 
terest in investigating the origin and degradation of 
inositol phosphates known to be involved in intra- 
cellular Ca2+ mobilisation. We believe the reversi- 
ble electropermeabilisation protocol outlined in 
this paper allows a higher incorporation of exter- 
nally applied [3H]inositol into platelet phospho- 
lipid pools than existing procedures. During the 
course of these studies a similar electro- 
permeabilisation approach has been used by 
another group to achieve high incorporation of 
[3H]inositol into the phosphoinositide pool of Dic- 
tyostelium cells [24]. 
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